The Use of Combined Motor Imagery and Action Observation to Evaluate the Influence on Functional Parameters Such as Strength, Range of Motion, Pain or Fear of Movement Among Others, in Females Breast Cancer Survivors.

Condition(s) studied

Investigational drug(s) / intervention(s)

Motor imagery combined with action observation: To observe and imaging one action with a video resource. Not virtual reality.

Study summary

The aim of this study is to evaluate the effectivity of the combined motor imagery and action observation therapies to improve functional parameters such as strenght, range of motion, pain or fear of movements among others in relation to upper limb in breast cancer survivors. The main question it aims to answer is: Will a combined therapy of motor imagery and action observation improve the strenght, rang of motion, pain, limb diameter and fear of movement of the upper limb in breast cancer survivor females? The participants will be part of the IM-OA23 proyect that consist on seeing some diferent videos about upper limb mobility and then they'll have to imagine the movements and to performed themselves. Researches will compare two groups (control group and intervention group) to evaluate the diferences between them.

Eligibility

Primary outcome measure(s)

• Sthrength — From enrollement to the end of the treatment at 6 weeks and 3 month after
  The grip strength of the hand of the affected limb shall be studied, using a dynamometer.
• Range of Motion — From enrollement to the end of the treatment at 6 weeks and 3 month after
  The measurement of the degrees of movement of the shoulder joint by means of a goniometer. The movements of flexion, abduction and internal and external rotation shall be studied using previously established reference points. external rotation, using previously established reference points
• Pain intensity — From enrollement to the end of the treatment at 6 weeks and 3 month after
  Pain intensity will be measured by Visual Analogue Scale (VAS). Participants will have to score their pain on a range from 0 to 10 where 0 means "no pain at all" and 10 "my pain is as bas as it could possibly be".
• Limb diameter — From enrollement to the end of the treatment at 6 weeks and 3 month after
  Limb diameter will be measured by a measuring tape. The measurement is taken at the midpoint between the acromion and the olecranon, the tape being perpendicular to the limb without compressing the area. The midpoint is located with an elbow flexion of 90 degrees and then the measurement is taken with the elbow in extension, the result is expressed in centimetres.
• Fear of movement — From enrollement to the end of the treatment at 6 weeks and 3 month after
  Fear of movement will be measured by the TSK questionnaire
• Imagery — From enrollement to the end of the treatment at 6 weeks and 3 month after
  Imagery will be assessed using the Movement Imagery Questionnaire revised second edition (MIQ-RS)

Trial sites (3)

More Fundacion Miguel Servet trials in Spain

Other trials for the same condition